Methodological issues in analyzing psychological test scores in pediatric clinical trials

Journal of Developmental and Behavioral Pediatrics

Volumn 21, Issue 2, 2000, Pages 141-150

  Lindsey, Jane C ^a   O'Donnell, Karen ^b   Brouwers, Pim ^c  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical trials; Floor scores; Longitudinal data

Indexed keywords

AGE; CHILD; CHILD PSYCHOLOGY; CLINICAL TRIAL; FEMALE; HUMAN; INFANT; MALE; PEDIATRICS; PRESCHOOL CHILD; PSYCHOLOGIC TEST; REVIEW; STANDARD; STATISTICAL ANALYSIS; STATISTICAL MODEL;

AGE FACTORS; CHILD; CHILD PSYCHOLOGY; CHILD, PRESCHOOL; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INFANT; MALE; MODELS, STATISTICAL; PEDIATRICS; PSYCHOLOGICAL TESTS;

EID: 0034170741     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004703-200004000-00010     Document Type: Article

References (31)

1. Bayley N: Bayley Scales of Infant Development. San Antonio, TX, The Psychological Corporation, 1969
2. Bayley N: Bayley Scales of Infant Development, 2nd ed. San Antonio, TX, The Psychological Corporation, 1993
3. McCarthy D: McCarthy Scales of Children's Ability. Cleveland, OH, The Psychological Corporation, 1970
4. Wechsler D: Wechsler Intelligence Scale for Children-Revised. San Antonio, TX, The Psychological Corporation, 1974
5. Wechsler D: Wechsler Intelligence Scale for Children, 3rd ed. San Antonio, TX, The Psychological Corporation, 1991
6. Mulhern RK, Ochs J, Fairclough D: Deterioration of intellect among children surviving leukemia: IQ test changes modify estimates of treatment toxicity. J Consult Clin Psychol 60:477-480, 1992
7. McKinney F, Maha M, Connor E, et al: A multicenter trial of oral zidovudine in children with advanced human immunodeficiency disease. N Engl J Med 324:1018-1025, 1991
8. Englund JA, Baker CJ, Rakino C, et al: Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med 336:1704-1712, 1997
9. Laird NM: Missing data in longitudinal studies. Stat Med 7:305-315, 1988
10. Brady M, McGrath N, Brouwers P, et al: Randomized study of the tolerance and efficacy of high versus low dose zidovudine in human immunodeficiency virus-infected infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). J Infect Dis 173:1097-1106, 1996
11. Pizzo PA, Eddy J, Falloon J, et al.: Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 319:889-96, 1988
12. Slymen DJ, de Peyster A, Donohoe RR: Hypothesis testing with values below detection limit in environmental studies. Environ Sci Technol 28:898-902, 1994
13. Lindsey JC, Brouwers P: Intra- and extrapolation of age-equivalent scores for the Bayley II: A comparison of three methods of estimation. Clin Neuropharmacol 22(suppl 1):44-53, 1999
14. Newman MC, Dixon PM, Looney BB, Pinder JE: Estimating mean and variance for environmental samples with below detection limit observations. Water Resour Bull 25:905-915, 1989
15. Helsel DR: Statistical treatment of data below the detection limit. Environ Sci Technol 24:1766-1774, 1990
16. Moulton LH, Halsey NA: A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics 51:1570-1578, 1995
17. SAS Procedures Guide: SAS/STAT Software. Cary, NC, SAS Institute, 1996
18. Naglieri JA: Extrapolated developmental indices for the Bayley Scales of Infant Development. Am J Ment Defic 25:548-550, 1981
19. Harrison PL, Naglieri JA: Extrapolated general cognitive indexes on the McCarthy Scales for Gifted and Mentally Retarded Children. Psychol Rep 43:1291-1296, 1978
20. Levenson RL, Zino TC: Using McCarthy scales extrapolated general cognitive indexes below 50: Some words of caution. Psychol Rep 45:350, 1979
21. Sattler JM: Assessment of Children , 3rd ed. San Diego, CA, Jerome M. Sattler, 1988
22. Rasbury WC, McCoy JG, Perry NW Jr: Relations of scores on WPPSI and WISC-R at a 1-year interval. Percept Mot Skills 44:695-698, 1977
23. Hartmann DP: Design, measurement and analysis: Technical issues in developmental research, in Bornstein MH, Lamb ME (eds): Developmental Psychology: An Advanced Textbook. Hillsdale, NJ, Lawrence Erlbaum Associates, 1992, pp 78-87
24. Fennell EB: Pediatric and adolescent patients, in Mohr E, Brouwers P (eds): Handbook of Clinical Trials: The Neurobehavioral Approach. Amsterdam, Holland, Swets and Zeitlinger, 1991, pp 165-183
25. Raboud JM, Montaner JSG, Thorne A, et al: Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 12:46-55, 1996
26. Schluchter MD: Methods for the analysis of informatively censored longitudinal data. Stat Med 11:1861-1870, 1992
27. Lindsey JC, McGrath, NM: Interpreting treatment differences when patients drop out of a clinical trial. AIDS Patient Care STDS 12:275-285, 1998
28. Diggle P, Kenward MG: Informative drop-out in longitudinal data analysis (with discussion). Appl Stat 43:49-93, 1994
29. Aylward GP, Verhulst SJ: Data analysis techniques in behavioral pediatrics: Some practical advice. J Dev Behav Pediatr 12:370-377, 1991
30. Rosner B: Fundamentals of Biostatistics. Boston, MA, Duxbury Press, 1988
31. Raskino C, Pearson D, Baker CJ, et al: Neurologic, neurocognitive and brain growth outcomes in HIV-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 104:e32, 1999